US 8188096
Protein kinase targeted therapeutics
granted A61KA61K31/50A61K45/06
Quick answer
US patent 8188096 (Protein kinase targeted therapeutics) held by Northwestern University expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/50, A61K45/06, A61P, A61P29/00